Cencora to take majority control of OneOncology
Dec 15 (Reuters) - U.S. drug distributor Cencora COR.N said on Monday it will take majority control of cancer care network OneOncology in a deal that values the business at $7.4 billion, as it moves to expand services for community oncology practices. (Reporting by Padmanabhan Ananthan in Bengaluru) ((Padmanabhan.Ananthan@thomsonreuters.com;))